Cenmox ( Amoxicillin )

Buy Cenmox (Amoxicillin) without prescription in Canada

In our Canadian pharmacy, you can buy Cenmox (Amoxicillin) without a prescription, with delivery across Canada within 5‑14 days. Discreet and anonymous packaging.

Cenmox (amoxicillin trihydrate) is a broad‑spectrum penicillin antibiotic used to treat a wide variety of bacterial infections, including those of the respiratory tract, middle ear, sinuses, skin, and urinary tract. It works by binding to penicillin‑binding proteins (PBPs) in the bacterial cell wall, thereby inhibiting the final transpeptidation step of peptidoglycan synthesis and leading to cell lysis and death. It is effective against both Gram‑positive and Gram‑negative organisms, although many bacteria have now developed resistance through beta‑lactamase production.

Usual adult dose: For most mild to moderate infections, the standard dose is 250 mg to 500 mg taken orally every 8 hours, or 500 mg to 875 mg every 12 hours, depending on the severity and site of infection. For severe infections or those caused by less susceptible organisms, doses up to 875 mg every 8 hours may be used. The tablets should be swallowed whole with a full glass of water and may be taken with or without food; taking with food can help reduce gastrointestinal upset. Therapy should be continued for at least 48 to 72 hours after signs and symptoms have resolved, and for streptococcal infections, a full 10‑day course is recommended to prevent rheumatic fever.

Dosage form: Oral capsules or film‑coated tablets containing 250 mg or 500 mg of amoxicillin (as amoxicillin trihydrate). A 125 mg/5 mL and 250 mg/5 mL oral suspension is also available for paediatric use.

Onset of action: Amoxicillin is rapidly absorbed, with peak serum concentrations reached within 1 to 2 hours after an oral dose. Clinical improvement, such as fever reduction and symptom relief, is typically observed within 24 to 72 hours of starting therapy, although the full course must be completed to ensure eradication of the infection.

Duration of action: The elimination half‑life of amoxicillin is approximately 1 to 1.5 hours in patients with normal renal function. The antibiotic effect persists for several hours after each dose, supporting 8‑hourly or 12‑hourly dosing regimens. Therapeutic concentrations in tissues and urine remain above the minimum inhibitory concentration (MIC) for susceptible organisms throughout the dosing interval when taken as prescribed.

Alcohol recommendation: Alcohol consumption does not directly interfere with the antibacterial action of Amoxicillin. However, alcohol should be limited or avoided during treatment because it can worsen gastrointestinal side effects such as nausea and diarrhoea, impair the body’s immune response to infection, and contribute to dehydration. Heavy alcohol use may also place additional strain on the liver.

Most common side effects: Diarrhoea, nausea, vomiting, and skin rash. These are generally mild and self‑limiting. The most concerning adverse effect is a hypersensitivity (allergic) reaction, which can range from mild maculopapular rash to life‑threatening anaphylaxis. Other serious adverse effects include Clostridioides difficile‑associated diarrhoea, acute interstitial nephritis, and, rarely, severe cutaneous adverse reactions such as Stevens‑Johnson syndrome. Patients with a history of penicillin allergy should not take amoxicillin.

Would you like to try Cenmox (Amoxicillin) without a prescription?

General Information about Cenmox (Amoxicillin)

• INN (International Nonproprietary Name): Amoxicillin (as amoxicillin trihydrate).
• Brand names available in Canada: Cenmox® is not a marketed brand in Canada. Amoxicillin is widely available in Canada as a generic under manufacturer‑branded names such as APO‑Amoxi (Apotex Inc.), TEVA‑Amoxicillin (Teva Canada Limited), Sandoz Amoxicillin (Sandoz Canada Inc.), PMS‑Amoxicillin (Pharmascience Inc.), and others. The historical brand names Amoxil® and Novamoxin® are no longer actively marketed. Our pharmacy supplies internationally sourced Cenmox, which contains the identical active ingredient, through the international supply chain for personal importation.
• ATC code: J01CA04 (penicillins with extended spectrum).
• Dosage forms and strengths: Oral capsules or film‑coated tablets: 250 mg and 500 mg of amoxicillin (as amoxicillin trihydrate). Powder for oral suspension: 125 mg/5 mL and 250 mg/5 mL after reconstitution.
• Manufacturers in Canada: Apotex Inc., Teva Canada Limited, Sandoz Canada Inc., Pharmascience Inc., and numerous other generic pharmaceutical companies. Cenmox is manufactured internationally and imported for personal use.
• Registration status in Canada: Approved by Health Canada. Amoxicillin has been available in Canada since the 1970s and is one of the most commonly prescribed antibiotics. Multiple generic formulations are currently marketed and available by prescription. The specific Cenmox brand has not been issued a Notice of Compliance; the active ingredient, amoxicillin, is approved under various generic DINs.
• OTC / Rx classification: Prescription only (Rx). Schedule I drug under the Controlled Drugs and Substances Act. A valid prescription from a licensed Canadian healthcare professional is required.

Mechanism of Action and Pharmacology

Amoxicillin is a semisynthetic aminopenicillin belonging to the beta‑lactam class of antibiotics. Its mechanism of action involves binding to specific penicillin‑binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. This binding inhibits the transpeptidase enzyme that catalyzes the cross‑linking of peptidoglycan chains, an essential step in cell wall biosynthesis. The result is a weakened cell wall that cannot withstand osmotic pressure, leading to cell lysis and death. Amoxicillin is bactericidal against susceptible organisms and exhibits activity against both Gram‑positive aerobes (e.g., Streptococcus pneumoniae, Streptococcus pyogenes) and many Gram‑negative aerobes (e.g., Haemophilus influenzae, Escherichia coli, Proteus mirabilis). However, it is susceptible to degradation by beta‑lactamases (penicillinases) produced by many staphylococci and Gram‑negative organisms; in such cases, combination with a beta‑lactamase inhibitor such as clavulanic acid restores its activity.

Amoxicillin is well absorbed after oral administration, with an absolute bioavailability of 74‑92%, depending on the dose. Absorption is not significantly affected by food, although taking the medication with a meal may reduce gastrointestinal upset. Peak plasma concentrations are achieved 1 to 2 hours after dosing. The drug is widely distributed into body tissues and fluids, including the middle ear, sinuses, bronchial secretions, and urine. Approximately 20% of the drug is bound to plasma proteins. Amoxicillin is excreted primarily by the kidneys, with about 60‑70% of an oral dose eliminated unchanged in the urine within 6 to 8 hours. The elimination half‑life is 1 to 1.5 hours in patients with normal renal function; this is prolonged in neonates, the elderly, and those with renal impairment. Amoxicillin is removed by haemodialysis.

Indications

• Respiratory tract infections: Acute bacterial sinusitis, acute otitis media, pharyngitis/tonsillitis (Group A Streptococcus), community‑acquired pneumonia, and acute exacerbations of chronic bronchitis caused by susceptible organisms.
• Urinary tract infections (UTIs): Uncomplicated acute cystitis caused by Escherichia coli or other susceptible Gram‑negative organisms.
• Skin and soft tissue infections: Mild to moderate cellulitis and erysipelas caused by susceptible streptococci and staphylococci (non‑beta‑lactamase‑producing).
• Gastrointestinal infections: Helicobacter pylori eradication (in combination with a proton pump inhibitor and clarithromycin or metronidazole) for peptic ulcer disease.
• Other: Lyme disease (early localized or early disseminated), endocarditis prophylaxis (for high‑risk patients undergoing dental procedures, although amoxicillin is no longer routinely recommended for this indication in Canada), and as part of multi‑drug regimens for certain infections.

Important Warnings and Precautions

At‑risk groups

• Pregnancy: Amoxicillin is generally considered safe for use during pregnancy and is classified as a Pregnancy Category B drug. Extensive clinical experience has not demonstrated an increased risk of fetal harm. It is commonly prescribed for urinary tract infections and other bacterial infections in pregnant women. However, it should only be used when clearly needed and under medical supervision.
• Breastfeeding: Amoxicillin is excreted in human breast milk in low concentrations. Although generally considered compatible with breastfeeding, it may cause diarrhoea, candidiasis, or allergic sensitization in the nursing infant. A decision should be made whether to discontinue breastfeeding or to discontinue the drug, taking into account the importance of the medication to the mother.
• Paediatrics: Amoxicillin is widely used in children of all ages, including neonates. Dosing is weight‑based (typically 20‑45 mg/kg/day in divided doses, depending on the indication). The oral suspension formulations are used for younger children. Safety and efficacy are well established.
• Elderly: No dose adjustment is required based on age alone. However, elderly patients are more likely to have decreased renal function, and dosage should be adjusted according to creatinine clearance if renal impairment is present. Monitoring for gastrointestinal side effects, including C. difficile‑associated diarrhoea, is recommended.
• Renal impairment: Amoxicillin is primarily excreted by the kidneys. For patients with a creatinine clearance of 10‑30 mL/min, the dosing interval should be extended to every 12 hours. For those with creatinine clearance below 10 mL/min, the interval should be extended to every 24 hours. Haemodialysis patients should receive an additional dose after dialysis.
• Allergy and hypersensitivity: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving penicillin therapy. Before initiating amoxicillin, careful inquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, or other beta‑lactam antibiotics. Approximately 10% of penicillin‑allergic patients will also be allergic to cephalosporins. If a hypersensitivity reaction occurs, the drug should be discontinued immediately and appropriate emergency treatment instituted.
• Clostridioides difficile‑associated diarrhoea (CDAD): As with many antibiotics, amoxicillin use can lead to overgrowth of C. difficile and the development of pseudomembranous colitis, which can range in severity from mild diarrhoea to fatal colitis. CDAD must be considered in any patient who develops diarrhoea during or up to 2 months after antibiotic therapy.
• Infectious mononucleosis: Amoxicillin should not be used in patients with suspected or confirmed infectious mononucleosis (caused by Epstein‑Barr virus) because of the very high risk of developing a widespread, non‑allergic maculopapular rash that is not a true penicillin allergy. This rash is benign and resolves after discontinuation but can be mistaken for an allergic reaction.
• Antibiotic resistance: To reduce the development of drug‑resistant bacteria and maintain the effectiveness of amoxicillin, the drug should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. Culture and sensitivity information should be used to guide therapy when available.

Driving and alcohol

Amoxicillin is not expected to impair the ability to drive or operate machinery. Some patients may experience dizziness or fatigue as part of the underlying infection. Alcohol consumption does not have a direct pharmacokinetic interaction with amoxicillin, but it should be limited or avoided during treatment because it can worsen gastrointestinal side effects such as nausea and diarrhoea, impair immune function, and contribute to dehydration. Heavy alcohol consumption can also place additional strain on the liver, which may be relevant in patients with pre‑existing hepatic impairment.

Dosage Instructions

• Mild to moderate infections (adults): 250 mg to 500 mg taken orally every 8 hours, or 500 mg to 875 mg every 12 hours. The choice of dose and interval depends on the severity of infection and the susceptibility of the suspected pathogen. For severe infections or those caused by less susceptible organisms, doses up to 875 mg every 8 hours may be used.
• Streptococcal pharyngitis/tonsillitis: 500 mg twice daily or 250 mg three times daily for 10 days. A full 10‑day course is essential to prevent acute rheumatic fever.
• Acute uncomplicated cystitis: 500 mg three times daily for 3 to 7 days, depending on local resistance patterns and clinical guidelines.
• H. pylori eradication (combination therapy): 1000 mg taken orally twice daily, in combination with a proton pump inhibitor and clarithromycin (or metronidazole), for 7 to 14 days.
• Early Lyme disease: 500 mg three times daily for 14 to 21 days.
• Renal impairment: For patients with a creatinine clearance of 10‑30 mL/min, the usual adult dose should be administered every 12 hours. For those with a creatinine clearance below 10 mL/min, the dose should be administered every 24 hours. Patients on haemodialysis should receive an additional dose after each dialysis session.
• Paediatric dosing: Dosing is based on body weight. The usual paediatric dose for mild to moderate infections is 20‑40 mg/kg/day, divided into three doses (every 8 hours). For acute otitis media, a high‑dose regimen of 80‑90 mg/kg/day divided into two doses may be used in areas with high rates of penicillin‑resistant pneumococci.
• Administration: The tablet or capsule should be swallowed whole with a full glass of water. It may be taken with or without food; taking it with food can help reduce stomach upset. The oral suspension must be shaken well before each use and measured with the calibrated device provided by the pharmacist. Complete the entire prescribed course of therapy, even if symptoms resolve earlier.
• Missed dose: If a dose is missed, take it as soon as remembered on the same day. If it is close to the time of the next scheduled dose, skip the missed dose and resume the regular schedule. Do not double the dose to make up for a missed one.

Side Effects and Contraindications

• Very common side effects (≥ 10%): Diarrhoea (up to 20%). This is usually mild and self‑limiting, but may be severe in some patients and can be a symptom of pseudomembranous colitis.
• Common side effects (1‑10%): Nausea, vomiting, skin rash (including maculopapular and urticarial eruptions), and candidiasis (oral thrush or vaginal yeast infection due to overgrowth of Candida).
• Uncommon but serious side effects: Hypersensitivity reactions including anaphylaxis, angioedema, and serum sickness. Clostridioides difficile‑associated diarrhoea (CDAD). Acute interstitial nephritis. Severe cutaneous adverse reactions (SCARs) including Stevens‑Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms (DRESS). Hepatotoxicity and cholestatic jaundice (rare). Haematological effects including leucopenia, thrombocytopenia, and haemolytic anaemia (very rare).
• Contraindications: Known hypersensitivity to amoxicillin, any penicillin, or any component of the formulation. A history of a severe and immediate hypersensitivity reaction (e.g., anaphylaxis) to another beta‑lactam agent (e.g., cephalosporin, carbapenem) is a contraindication. Amoxicillin should not be used in patients with infectious mononucleosis because of the very high risk of a drug‑related rash.

Drug Interactions

• Methotrexate: Penicillins may reduce the renal tubular secretion of methotrexate, increasing methotrexate serum concentrations and the risk of toxicity. Close monitoring of methotrexate levels and appropriate dose adjustment are required.
• Probenecid: Probenecid inhibits the renal tubular secretion of amoxicillin, increasing and prolonging amoxicillin serum concentrations. This interaction can be used therapeutically to achieve higher antibiotic levels but requires dose adjustment of amoxicillin when probenecid is co‑administered.
• Warfarin and other oral anticoagulants: Amoxicillin may enhance the anticoagulant effect of warfarin by reducing vitamin K production by gut flora. The International Normalised Ratio (INR) should be monitored more frequently during and after amoxicillin therapy, and the warfarin dose adjusted as necessary.
• Allopurinol: Concurrent administration of amoxicillin and allopurinol may increase the incidence of skin rash, particularly in hyperuricemic patients. The mechanism is unknown, but the combination should be used with caution.
• Oral contraceptives: Amoxicillin, like other broad‑spectrum antibiotics, may transiently reduce the efficacy of combined oral contraceptives by interfering with the enterohepatic circulation of ethinyl estradiol. A backup barrier method of contraception is recommended during treatment and for at least 7 days after completing the antibiotic course.
• Laboratory test interference: Amoxicillin may cause false‑positive results with certain urine glucose tests (e.g., Benedict’s solution, Fehling’s solution). Enzyme‑based glucose tests (e.g., Clinistix) are recommended. A positive direct Coombs test has been reported in some patients receiving high‑dose amoxicillin.

Practical Advice

• Administration: Take the medication exactly as prescribed. Swallow the tablet or capsule whole with a full glass of water; you may take it with food to reduce stomach upset. Space your doses evenly throughout the day. If you are taking the oral suspension, shake it well before use and measure the dose with the provided device. Complete the entire prescribed course, even if you start to feel better after a few days. Stopping the antibiotic too early may allow the bacteria to continue growing, leading to a relapse of the infection and promoting antibiotic resistance.
• Monitoring: No routine laboratory monitoring is required for healthy individuals on short‑term therapy. In patients with renal impairment, renal function should be assessed. For those on prolonged treatment (more than 2 weeks), periodic monitoring of liver and renal function, as well as complete blood counts, is recommended. Patients on warfarin should have their INR checked more frequently.
• Storage: Store tablets and capsules at room temperature (15‑30 °C) in a tightly closed container, protected from moisture and light. The oral suspension should be refrigerated (2‑8 °C) after reconstitution and used within 14 days; discard any unused portion after this time. Do not freeze. Keep all forms out of the reach and sight of children.
• Lifestyle: Drink plenty of fluids while taking this medication to stay hydrated, especially if you experience diarrhoea. Avoid alcohol, which can worsen gastrointestinal upset and hinder recovery. If you develop severe or watery diarrhoea, contact your doctor before using any anti‑diarrhoeal product, as this could be a sign of C. difficile colitis. Inform any healthcare professional that you are taking amoxicillin, particularly if you are scheduled for surgery or dental work.
• Missed dose: If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and return to your regular schedule. Never double the dose to catch up.
• When to seek medical review: Contact your doctor immediately if you develop signs of an allergic reaction (rash, hives, itching, swelling of the face, lips, or tongue, difficulty breathing), severe or watery/bloody diarrhoea, signs of liver problems (yellowing of the skin or eyes, dark urine, right upper abdominal pain), or any new or worsening symptoms. Seek emergency care for anaphylaxis (difficulty breathing, severe swelling, loss of consciousness).
• Disposal: Return unused or expired medication to a pharmacy for safe disposal. Do not flush down the toilet or discard in household waste.

Alternative Medications

• Amoxicillin‑clavulanate (Clavulin®, Augmentin®): The addition of the beta‑lactamase inhibitor clavulanate extends the spectrum of amoxicillin to include beta‑lactamase‑producing strains of Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis, and Bacteroides fragilis. It is used for more resistant respiratory, skin, and bite infections.
• Penicillin V (Pen‑Vee®): The natural penicillin is narrower in spectrum and remains the drug of choice for confirmed streptococcal pharyngitis and for prevention of rheumatic fever. It is less well absorbed than amoxicillin.
• Cephalexin (Keflex®): A first‑generation cephalosporin that is an alternative for patients with non‑anaphylactic penicillin allergy. It covers similar Gram‑positive organisms and is commonly used for skin and soft‑tissue infections, as well as uncomplicated UTIs.
• Doxycycline (Vibramycin®): A tetracycline antibiotic that covers many respiratory pathogens, atypical bacteria, and is the first‑line treatment for early Lyme disease. It is an alternative for penicillin‑allergic patients but should not be used in children under 8 years of age or during pregnancy.
• Azithromycin (Zithromax®): A macrolide antibiotic used for respiratory infections, particularly when atypical organisms (Mycoplasma, Chlamydia) are suspected. It is an alternative for penicillin‑allergic patients, but rates of macrolide resistance among pneumococci are a concern.
• Trimethoprim‑sulfamethoxazole (Septra®, Bactrim®): A sulfonamide combination used for uncomplicated UTIs, some respiratory infections, and skin infections caused by community‑associated MRSA. It is an alternative for penicillin‑allergic patients.
• Non‑pharmacological measures: Rest, adequate hydration, and symptomatic management with analgesics/antipyretics (e.g., acetaminophen, ibuprofen) are important supportive measures for bacterial infections.

Clinical Efficacy

Amoxicillin has been in clinical use since the early 1970s and is one of the most widely prescribed antibiotics globally. It has demonstrated high clinical and bacteriological cure rates for a broad range of community‑acquired infections. For streptococcal pharyngitis, a 10‑day course of amoxicillin 500 mg twice daily achieves eradication rates exceeding 90% and is considered first‑line therapy by the Infectious Diseases Society of America (IDSA) and Canadian guidelines. For acute otitis media in children, high‑dose amoxicillin (80‑90 mg/kg/day) is the recommended first‑line agent, achieving clinical success in 70‑85% of cases, depending on local pneumococcal resistance rates. In the treatment of uncomplicated lower urinary tract infections, amoxicillin 500 mg three times daily for 3‑7 days is effective, although resistance rates among E. coli have risen substantially in many Canadian communities; local antibiograms should be consulted. For H. pylori eradication, amoxicillin 1 gram twice daily in combination with clarithromycin and a proton pump inhibitor achieves eradication rates of 80‑90%. The drug’s excellent oral bioavailability, favourable safety profile, and low cost make it a cornerstone of antibiotic therapy. However, the emergence of beta‑lactamase‑mediated resistance has limited its empiric use in many clinical settings, and culture and sensitivity testing is recommended whenever possible. In Canada, amoxicillin remains available by prescription only and is listed on the World Health Organization Model List of Essential Medicines.

Important:

Cenmox (amoxicillin) is a prescription antibiotic that should be used only under the supervision of a qualified healthcare professional. It is intended to treat bacterial infections only and is not effective against viral infections such as the common cold or flu. Take the full prescribed course of this medication, even if your symptoms improve earlier. Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported with penicillins. Seek immediate medical attention if you develop signs of an allergic reaction such as rash, hives, itching, swelling of the face, lips, or tongue, or difficulty breathing. Diarrhoea is a common side effect, but if it becomes severe, watery, or bloody, contact your doctor immediately, as this may be a sign of a serious intestinal infection (C. difficile colitis). This medication should not be used in patients with a history of severe penicillin allergy or in those with infectious mononucleosis (glandular fever) due to a high risk of a non‑allergic rash. Inform your doctor if you have kidney disease, are pregnant or breastfeeding, or are taking any other medications, particularly warfarin, methotrexate, or allopurinol. This information is not a substitute for professional medical advice, diagnosis, or treatment.

Get Cenmox - Shipping across Canada